Search Results

AstraZeneca's Investigational COVID-19 Prevention Drug Reduces Risk of Infection in Immunocompromised Persons.

• Authors : Jennings, Sydney

Subjects: COVID-19 vaccines; IMMUNOCOMPROMISED patientsASTRAZENECA PLC

• Source: Patient Care (Online); 5/17/2024, p4-4, 1p

Record details

AstraZeneca at ATS 2024: Look for Late-Breaking Data on Novel Therapeutics for COPD.

Subjects: OBSTRUCTIVE lung disease treatment; GLYCOPYRROLATE; BIOPHARMACEUTICSASTRAZENECA PLC

• Source: Patient Care (Online); 5/9/2024, p3-3, 1p

Record details

AstraZeneca Launches Phase 3 THARROS Trial of Breztri to Reduce Cardiopulmonary Events in COPD.

• Authors : Halsey, Grace

Subjects: CARDIOVASCULAR diseases; FORMOTEROL; CHRONIC obstructive pulmonary diseaseASTRAZENECA PLC

• Source: Patient Care (Online); 3/15/2024, p1-1, 1p, 1 Color Photograph

Record details

Nirsevimab 90% Effective Against RSV Hospitalization among Infants, According to New CDC Data.

• Authors : Jennings, Sydney

Subjects: HOSPITAL care; IMMUNIZATION; RESPIRATORY diseasesCENTERS for Disease Control & Prevention (U.S.); ASTRAZENECA PLC

• Source: Patient Care (Online); 3/12/2024, p1-1, 1p, 1 Color Photograph

Record details

CLINICAL TRIALS NEWS.

Subjects: *CLINICAL drug trials; *CLINICAL trials; *PHARMACEUTICAL industryCV Therapeutics Inc. 796248110 CV Therapeutics Inc. CV Therapeutics Inc. 796248110 796248110 CV Therapeutics Inc. 796248110 CVTX; APPLIED Pharma Research SA ; ASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Applied Clinical Trials. Feb2007, Vol. 16 Issue 2, p16-18. 2p.

Record details

Clinical Trials News.

Subjects: *CLINICAL trials; *DRUG development; *ANTICHOLESTEREMIC agentsUNITED StatesSCHERING-Plough Corp. 054554290 SCHERING-Plough Corp. SCHERING-Plough Corp. 054554290 054554290 SCHERING-Plough Corp. 054554290 SGP; MERCK & Co. Inc. 001317064 MERCK & Co. Inc. MERCK & Co. Inc. 001317064 001317064 MERCK & Co. Inc. 001317064 MRK; ASTRAZENECA PLC ASTRAZENECA PLC ASTRAZENECA PLC AZN

• Source: Applied Clinical Trials. Feb2005, Vol. 14 Issue 2, p18-22. 3p.

Record details

Trials in progress.

Subjects: *CLINICAL trials; *MEDICAL experimentation on humansUNITED StatesCASTLE Creek Biosciences Inc. ; DOR BioPharma Inc. DOR BioPharma Inc. DOR BioPharma Inc. SNGX; BIOGENTECH Corp.

• Source: Applied Clinical Trials. Sep2004, Vol. 13 Issue 9, p16-18. 2p.

Record details

Roadmap to Implementing the EU Directive.

• Authors : O'Hare, Mary

Subjects: PHARMACEUTICAL policy; CLINICAL trials; MEDICINAL plantsASTRAZENECA PLC; EUROPEAN Union

• Source: Applied Clinical Trials; Jan2007, Vol. 16 Issue 1, p44-50, 5p

Record details

AstraZeneca.

Subjects: PHARMACEUTICAL industryASTRAZENECA PLC

• Source: Formulary; Oct2000 Resource Guide, Vol. 35 Issue 10, p10, 7p, 2 Charts

Record details

C-Suite Personality: Fit for Future?

• Authors : Noor, Waseem; Serikova, Saule

Subjects: PHARMACEUTICAL industry; BUSINESS enterprise ratings; CHARTS, diagrams, etc.ASTRAZENECA PLC

• Source: Pharmaceutical Executive; Jun2018, Vol. 38 Issue 6, p16-23, 8p

Record details